Current status of the development of trans-platinum antitumor drugs
- 4 August 2000
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 35 (2) , 109-120
- https://doi.org/10.1016/s1040-8428(00)00053-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- X-ray Structure of Cytotoxic trans-[PtCl2(dimethylamine)(isopropylamine)]: Interstrand Cross-Link Efficiency, DNA Sequence Specificity, and Inhibition of the B−Z TransitionJournal of Medicinal Chemistry, 2000
- DNA Modifications by a Novel Bifunctional Trinuclear Platinum Phase I Anticancer AgentBiochemistry, 1999
- The Mechanism of Action of Cisplatin: From Adducts to ApoptosisPublished by Wiley ,1999
- A mechanism-based, solution-phase method for screening combinatorial mixtures of potential platinum anticancer drugsJBIC Journal of Biological Inorganic Chemistry, 1998
- Platinum(II) complexes containing iminoethers: a trans platinum antitumour agentChemico-Biological Interactions, 1995
- A novel DNA structure induced by the anticancer bisplatinum compound crosslinked to a GpC site in DNANature Structural & Molecular Biology, 1995
- Sequence Specificity of DNA-DNA Interstrand Cross-Link Formation by Cisplatin and Dinuclear Platinum ComplexesBiochemistry, 1994
- New platinum antitumor complexesPublished by Elsevier ,1993
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI Journal of the National Cancer Institute, 1989
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970